Nationwide Recall Launched By The FDA On Mibelas 24 Fe Birth Control Pills

The Food and Drug Administration announced a nationwide recall on a brand birth control tablets, Mibelas 24 F-E.

The action is related to a packaging error, where the pills are “rotated 180 degrees within the wallet, reversing the weekly tablet orientation and making the lot number and expiration date no longer visible,” the FDA said.

The active tablets are pushed back, as the four non-hormonal placebo tablets are incorrectly positioned at the beginning of the sequence.

 

FDA Recalls Mibelas 24-F-E Birth Control Pills

“As a result of this packing error, oral contraceptive tablets that are taken out of sequence may place the user at risk for contraceptive failure and unintended pregnancy,” the agency said.

According to the FDA, no adverse effects related to the issue have been reported.

Lupin Pharmaceuticals distributed the birth control pills nationwide.

Lupin manufacturers several brands, including Suprax, InspiraChamber, Methylphenidate HCL, Alinia and Antara 90mg.

The company is notifying customers and distributors by a recall letter and is preparing for the return of all the recalled products.

Customers affected by the recalled products should notify their primary care physician and return them to the place of purchase.

This entry was posted in Maryland News and tagged , , , , , , , , , . Bookmark the permalink.

Leave a Reply